This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nanovation Therapeutics Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Anthony Tam: Innovator in mRNA Delivery Technology
Introduction
Anthony Tam is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA delivery systems. His innovative work focuses on enhancing the efficacy of mRNA therapies, which have become increasingly important in modern medicine.
Latest Patents
Anthony Tam holds a patent for an mRNA delivery composition. This patent describes a lipid nanoparticle designed for extrahepatic delivery of mRNA. The lipid nanoparticle comprises mRNA cargo, a phosphatidylcholine lipid content ranging from 0 to 70 mol %, an ionizable cationic lipid content between 5 mol % and 50 mol %, a sterol selected from cholesterol or its derivatives, and a hydrophilic polymer-lipid conjugate present at a lipid content of 0.5 mol % to 5 mol. The preparation of these lipid nanoparticles demonstrates a significant increase in gene expression of the mRNA in vivo, showcasing their potential for therapeutic applications.
Career Highlights
Anthony Tam is currently associated with Nanovation Therapeutics Inc., where he continues to advance his research in mRNA delivery systems. His work is pivotal in the ongoing development of innovative therapies that leverage the power of mRNA technology.
Collaborations
Throughout his career, Anthony has collaborated with notable colleagues, including Daniel Kurek and Maunish Barvalia. These collaborations have further enriched his research and contributed to the advancement of mRNA delivery technologies.
Conclusion
Anthony Tam is a key figure in the field of mRNA delivery technology, with a focus on developing effective lipid nanoparticle systems. His contributions are shaping the future of biotechnology and therapeutic interventions.